Company: G
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001398659-25-000109
Chunk: 40

Company: Genpact LTD
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 1
Chunk 40
---
 2,449 — — 2,450 Net settlement on vesting of restricted share units (Note 15)35,513 — (148)— — (148)Net settlement on vesting of performance units (Note 15)Stock repurchased and retired (Note 16)(1,935,320)(19)— (74,913)— (74,932)Expenses and taxes related to stock repurchased (Note 16)— — — (38)— (38)Stock-based compensation expense (Note 15)— — 19,726 — — 19,726 Comprehensive income (loss): Net income— — — 132,818 — 132,818 Other comprehensive income (loss)— — — — 3,997 3,997 Dividend ($0.1525 per common share, Note 16)— — — (26,939)— (26,939)Balance as of September 30, 2024176,347,167 $1,758 $1,922,042 $1,207,387 $(736,494)$2,394,693 

See accompanying notes to the Consolidated Financial Statements.

6

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Equity 

For the nine months ended September 30, 2024

(Unaudited)

(In thousands, except share count)

 Common sharesAccumulated OtherComprehensiveIncome (Loss)No. ofSharesAmountAdditional Paid-in CapitalRetainedEarningsTotalEquityBalance as of January 1, 2024179,494,132 $1,789 $1,883,944 $1,085,209 $(722,550)$2,248,392 Issuance of common shares on exercise of options (Note 15)135,051 1 3,930 — — 3,931 Issuance of common shares under the employee stock purchase plan (Note 15)261,281 3 8,236 — — 8,239 Net settlement on vesting of restricted share units (Note 15)307,298 3 (4,431)— — (4,428)Net settlement on vesting of performance units (Note 15)869,713 9 (16